OptimizeRx Corp
- Last sale
- Nov 12, 2026 · -0.22%
- Market cap
- $168.84M
- 18.91M shares
- Filings
- 1,020
Q3 2026+18.8% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived+290.6% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+74.6% FY25 yoy
- $168.84M
- 33.7×
- 1.8×
- 1.3×
- 11.78%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $109,429,000 | reported | |
| FY 2024 | 2024-12-31 | $92,127,000 | reported | |
| FY 2023 | 2023-12-31 | $71,522,000 | reported | |
| FY 2022 | 2022-12-31 | $1,025,000 revised | reported | |
| FY 2021 | 2021-12-31 | $4,516,668 revised | reported | |
| FY 2020 | 2020-12-31 | $43,313,323 | reported | |
| FY 2019 | 2019-12-31 | $24,598,274 | reported | |
| FY 2018 | 2018-12-31 | $21,206,363 | reported | |
| FY 2017 | 2017-12-31 | $12,127,422 | reported | |
| FY 2016 | 2016-12-31 | $7,751,462 | reported | |
| FY 2015 | 2015-12-31 | $7,220,678 | reported | |
| FY 2014 | 2014-12-31 | $6,502,962 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | — | $7.52M | $7.52M | — | 18.18M sh | +6.3% | — |
| FY2022 | — | $20.02M | $20.02M | — | 17.10M sh | −4.3% | 189.4% |
| FY2017 | — | $390.00K | $390.00K | — | 29.32M sh | −1.3% | — |
| FY2016 | — | $806.92K | $806.92K | — | 29.72M sh | +2.4% | — |
| FY2015 | — | $0.00 | $0.00 | — | 29.03M sh | +26.7% | 0.0% |
Segments
Products
LineFY2025ShareChange
Revenue recognized over time$109.21M100%+27.8%
Revenue recognized at a point in time$215.00K0.2%−96.8%
Total$109.43M
Other business services
OptimizeRx Corp is the 77th largest of the 133 covered companies the SEC files under this code, by revenue. SIC 7389
CompanyRevenueGrowthNet marginMarket cap
JANLJanel Corp$207.4M13.2%2.7%$58.1MCASSCass Information Systems Inc$190.8M5.3%18.4%$708.0MSGRPSPAR Group, Inc.$136.1M16.8%18.1%$10.8MDHXDHI Group, Inc.$127.8M9.9%10.6%$184.3MBAERBridger Aerospace Group Holdings, Inc.$122.8M24.6%3.4%$15.4M
OPRXOptimizeRx Corp (this company)$109.4M18.8%4.7%$168.8M
NOTEFiscalNote Holdings, Inc.$95.4M20.7%68.4%$304.7KPAYSPaysign, Inc.$82.0M40.5%9.2%$540.1MPOWWOutdoor Holding Co$51.1M3.5%6.9%$256.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR